This inventor holds 5 USPTO granted patents. Top assignees: Millennium Pharmaceuticals Limited, Millenium Pharmaceuticals, Inc.. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2003
Title: The Innovations of Andappan Murugaiah Subbaiah Murugaiah
Introduction
Andappan Murugaiah Subbaiah Murugaiah is a notable inventor based in Tamil Nadu, India. He has made significant contributions to the field of chemistry, particularly in the development of cyclic oxygen compounds. With a total of five patents to his name, his work has implications in pharmaceutical applications and therapeutic methods.
Latest Patents
His latest patents include "Substituted oxygen alicyclic compounds, including methods for synthesis thereof." This invention provides new methods for the preparation of cyclic oxygen compounds, such as 2,5-disubstituted tetrahydrofurans, 2,6-disubstituted tetrahydropyrans, 2,7-disubstituted oxepanes, and 2,8-oxocanes. Additionally, he has developed methods for the synthesis of substituted tetrahydrofuran compounds, including the pharmaceutically active compound 2-(4-fluorophenoxymethyl)-5-(4-N-hydroxyureidyl-1-butynyl)-tetrahydrofuran and its precursors.
Career Highlights
Throughout his career, Andappan has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to various innovative projects and research initiatives.
Collaborations
Andappan has collaborated with notable individuals in his field, including Mukund Shankar Chorghade and Mukund Keshao Gurjar. These collaborations have further enhanced his research and development efforts.
Conclusion
Andappan Murugaiah Subbaiah Murugaiah's contributions to the field of chemistry and his innovative patents demonstrate his commitment to advancing pharmaceutical science. His work continues to have a significant impact on the development of new therapeutic methods and compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile